Literature DB >> 1551977

Differentiation between active and inactive human brucellosis by measuring antiprotein humoral immune responses.

F A Goldbaum1, C P Rubbi, J C Wallach, S E Miguel, P C Baldi, C A Fossati.   

Abstract

A preparation of Brucella abortus cytoplasmic proteins was depleted of lipopolysaccharide (LPS) by immunoadsorption with a monoclonal antibody (MAb), BC68, specific for the O antigen of B. abortus smooth LPS. Two enzyme-linked immunosorbent assay (ELISA) systems were developed and used in this study. The first system includes an LPS-free cytoplasmic protein preparation; the second one was based on antigen capture on MAb BC68. By using these systems, we have demonstrated that 94% (33 of 35) of the brucellosis patients studied showed immunoglobulin G antiprotein response and also that all of the patients showed a strong anti-LPS reactivity. Thirty-six serologically positive individuals with no active infection at the time of examination (SPI) were also included. No immunoglobulin G antibodies against proteins were detected in 34 of them (92%), whereas 31 SPI (86%) showed various degrees of anti-LPS reactivity. The use of the LPS-free protein extract in ELISAs made it possible to establish differential reactivity patterns between active and inactive brucellosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551977      PMCID: PMC265118          DOI: 10.1128/jcm.30.3.604-607.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Specific antibodies detected during relapse of human brucellosis.

Authors:  T Pellicer; J Ariza; A Foz; R Pallares; F Gudiol
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

2.  Factors affecting the sensitivity of Limulus lysate.

Authors:  J D Sullivan; S W Watson
Journal:  Appl Microbiol       Date:  1974-12

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Properties of the outer membrane of Brucella.

Authors:  I Moriyón; C Gamazo; R Díaz
Journal:  Ann Inst Pasteur Microbiol       Date:  1987 Jan-Feb

5.  Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis.

Authors:  V C Tsang; J M Peralta; A R Simons
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Preparation of monoclonal antibodies: strategies and procedures.

Authors:  G Galfrè; C Milstein
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

8.  Biological activities of Brucella abortus lipopolysaccharides.

Authors:  E Moreno; D T Berman; L A Boettcher
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

9.  Outer membrane proteins of Brucella abortus: isolation and characterization.

Authors:  D R Verstreate; M T Creasy; N T Caveney; C L Baldwin; M W Blab; A J Winter
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

10.  Isolation, purification, and partial characterization of Brucella abortus matrix protein.

Authors:  I Moriyon; D T Berman
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

View more
  10 in total

1.  Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice.

Authors:  R A Bowden; G C Racaro; P C Baldi
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Humoral immune responses of Brucella-infected cattle, sheep, and goats to eight purified recombinant Brucella proteins in an indirect enzyme-linked immunosorbent assay.

Authors:  J J Letesson; A Tibor; G van Eynde; V Wansard; V Weynants; P Denoel; E Saman
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

3.  Seroprevalence of brucella antibodies among persons in high-risk occupation in Lebanon.

Authors:  G F Araj; R A Azzam
Journal:  Epidemiol Infect       Date:  1996-10       Impact factor: 2.451

4.  Antibody and delayed-type hypersensitivity responses to Ochrobactrum anthropi cytosolic and outer membrane antigens in infections by smooth and rough Brucella spp.

Authors:  J Velasco; R Díaz; M J Grilló; M Barberán; C Marín; J M Blasco; I Moriyón
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

5.  Detection of antibodies to Brucella cytoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis.

Authors:  P C Baldi; G F Araj; G C Racaro; J C Wallach; C A Fossati
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

6.  Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9.

Authors:  P C Baldi; G H Giambartolomei; F A Goldbaum; L F Abdón; C A Velikovsky; R Kittelberger; C A Fossati
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

7.  Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production.

Authors:  V Weynants; J Godfroid; B Limbourg; C Saegerman; J J Letesson
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

8.  Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens.

Authors:  Li Liang; Diana Leng; Chad Burk; Rie Nakajima-Sasaki; Matthew A Kayala; Vidya L Atluri; Jozelyn Pablo; Berkay Unal; Thomas A Ficht; Eduardo Gotuzzo; Mayuko Saito; W John W Morrow; Xiaowu Liang; Pierre Baldi; Robert H Gilman; Joseph M Vinetz; Renée M Tsolis; Philip L Felgner
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

9.  Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis.

Authors:  F A Goldbaum; J Leoni; J C Wallach; C A Fossati
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

10.  Human infection with M- strain of Brucella canis.

Authors:  Jorge C Wallach; Guillermo H Giambartolomei; Pablo C Baldi; Carlos A Fossati
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.